X

Stay Connected

Sign Up for Updates

We are creating a place where we can share ideas, provide the perspective of America's biopharmaceutical companies and, most importantly, listen to you.

Government “negotiation” could have devastating consequences for Medicare enrollees

By Gabby Migliara  |    July 23, 2021
Some members of Congress are considering significant changes to Medicare that could have a devastating effect on millions of Americans. Proponents call these changes government “negotiation,” but...   Read More

Protecting Medicare from government interference

By Gabby Migliara  |    July 21, 2021
For more than a decade, Medicare Part D has provided seniors and people with disabilities with affordable and comprehensive prescription medicine coverage. Several surveys show that more than 9 in...   Read More

Data shows voters strongly support protecting access to their medicines

By Mark Keida  |    July 15, 2021
In our current health care system, the Medicare Part D program helps ensure seniors and people with disabilities have access to the prescription medicines they need. While more than 90% of seniors...   Read More

Medicare “negotiation” proposals threaten Americans’ access to medicines

By Gabby Migliara  |    June 30, 2021
While more than 90% of seniors and people with disabilities report that they are very satisfied with their Medicare Part D prescription drug coverage, they also acknowledge concerns with rising...   Read More

Out-of-pocket trends in Medicare Part D show rising costs for seniors

By Katie Koziara  |    May 24, 2021
A new study based on IQVIA data shows alarming trends in rising out-of-pocket costs for brand medicines among Medicare Part D beneficiaries with serious and complex conditions like cancer, HIV and...   Read More

The ABCs (and Ds) of Medicare

By Gabby Migliara  |    May 13, 2021
For nearly 60 years, Medicare has helped pay for medical care for Americans over the age of 65, as well as younger Americans with certain medical needs. Medicare has many different programs, all...   Read More

ICYMI: Bipartisan lawmakers urge new administration to oppose changes to six protected classes policy

By Tom Wilbur  |    March 11, 2021
On January 19, 2021 – the last full day of the Trump administration – CMS released a Part D Payment Modernization Model Request for Applications (RFA) for calendar year 2022. This model would...   Read More

Key excerpts: PhRMA submits comments to keep the six protected classes protected

By Tom Wilbur  |    February 19, 2021
Earlier this month, PhRMA submitted comments to CMS regarding the Part D Payment Modernization Model Request for Applications (RFA) for calendar year 2022. This RFA was released on January 19,...   Read More

Action needed to preserve the six protected classes

By Tom Wilbur  |    February 3, 2021
In the final hours of the previous Administration’s time in office, the Center for Medicare & Medicaid Innovation (the Innovation Center) (CMMI) announced new changes for CY 2022 to an existing...   Read More

Key facts: The final rebate rule will be a positive change for patients

By Tom Wilbur  |    January 19, 2021
While drug middlemen are making billions of dollars in record profits at a time when millions of Americans are facing financial struggles, they are also suing to block the final rebate rule, a...   Read More

Search the Catalyst

View Posts by Topic

see all

View Posts by Date

see all

Subscribe to Email Updates